-
Int. J. Radiat. Oncol. Biol. Phys. · Jul 2018
Hypopituitarism After Single-Fraction Pituitary Adenoma Radiosurgery: Dosimetric Analysis Based on Patients Treated Using Contemporary Techniques.
- Christopher S Graffeo, Michael J Link, Paul D Brown, William F Young, and Bruce E Pollock.
- Department of Neurological Surgery, Mayo Clinic College of Medicine, Rochester, Minnesota.
- Int. J. Radiat. Oncol. Biol. Phys. 2018 Jul 1; 101 (3): 618-623.
PurposeTo analyze factors associated with post-stereotactic radiosurgery (SRS) hypopituitarism among radiation-naïve patients with pituitary adenomas who underwent single-fraction SRS between 2007 and 2014.Methods And MaterialsThis was a retrospective review of 97 patients having single-fraction SRS from 2007 until 2014. Eligible patients had no history of prior radiation, normal age- and sex-specific pituitary function before SRS, and at least 24 months of endocrine follow-up. Forty patients (41%) had hormone-secreting tumors; 57 patients had nonsecreting tumors (59%). The median prescription isodose volume was 2.8 cm3 (interquartile range [IQR], 1.3-4.7); the median tumor margin dose was 20 Gy (IQR, 15-25 Gy).ResultsThe median follow-up after SRS was 48 months (IQR, 34-68 months). Twenty-seven patients (28%) developed pituitary insufficiency at a median of 22 months (IQR, 12-36 months) after SRS. The rate of new endocrine deficits was 17% at 2 years (95% confidence interval [CI] 10%-25%) and 31% at 5 years (95% CI 20%-42%). Male sex (hazard ratio [HR] 2.38, 95% CI 1.05-5.26, P = .04), smaller pituitary gland volume (HR 0.99, 95% CI 0.99-0.99, P = .01), and higher mean pituitary gland dose (HR 1.31, 95% CI 1.16-1.47, P < .001) were associated with post-SRS hypopituitarism in multivariable analysis. The rate of hypopituitarism for patients with a mean gland dose of <11.0 Gy at 2 years was 2% (95% CI 0%-4%) and at 5 years was 5% (95% CI 0%-11%), whereas rate of hypopituitarism for patients with a mean gland dose of ≥11.0 Gy at 2 years was 31% (95% CI 17%-43%) and at 5 years was 51% (95% CI 34%-65%).ConclusionsHypopituitarism after pituitary adenoma SRS increases in a time- and dose-dependent manner. Reducing the radiation exposure to the identifiable gland to a mean dose < 11.0 Gy whenever feasible may lower the incidence of new hormonal deficits after pituitary adenoma SRS.Copyright © 2018 Elsevier Inc. All rights reserved.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*
,_underline_
or**bold**
. - Superscript can be denoted by
<sup>text</sup>
and subscript<sub>text</sub>
. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3.
, hyphens-
or asterisks*
. - Links can be included with:
[my link to pubmed](http://pubmed.com)
- Images can be included with:
![alt text](https://bestmedicaljournal.com/study_graph.jpg "Image Title Text")
- For footnotes use
[^1](This is a footnote.)
inline. - Or use an inline reference
[^1]
to refer to a longer footnote elseweher in the document[^1]: This is a long footnote.
.